Tidligere arrangementer - Side 8
Tema for forelesningen er "Renhetsbestemmelse av farmas?ytiske r?varer med vannfri titrering".
Master i teknologi Renate Kristianslund ved Farmas?ytisk institutt vil forsvare sin avhandling for graden ph.d: Organocatalyzed Halocyclizations: New Methods and Application in Total Synthesis.
Master i teknologi Renate Kristianslund ved Farmas?ytisk institutt avholder pr?veforelesning over oppgitt emne: Recent Advances in Stereoselective Alkene Halogenation Reactions: Application to Medicinal Chemistry and Natural Product Synthesis.
Master i farmasi Veronica Krogstad ved Farmas?ytisk institutt vil forsvare sin avhandling for graden ph.d: Studies of hepatic, intestinal and renal pharmacokinetic processes contributing to variability in drug disposition and response.
Master i farmasi Veronica Krogstad ved Farmas?ytisk institutt avholder pr?veforelesning over oppgitt emne: Translation of in vitro metabolism/transport data to in vivo using physiologically based pharmacokinetic modelling.
From the Womb to the Grave - Life-course Pharmacoepidemiology
Massimiliano Pio di Cagno holder sin pr?veforelesning for stillingen som f?rsteamanuensis i galenisk farmasi.
Nicky Thomas holder sin pr?veforelesning for stillingen som f?rsteamanuensis i galenisk farmasi.
Korbinian L?bmann holder sin pr?veforelesning for stillingen som f?rsteamanuensis i galenisk farmasi.
Master i farmasi Lars Peter Engeset Austdal ved Farmas?ytisk institutt vil forsvare sin avhandling for graden ph.d: New models for nonclinical safety assessment: targeting hallmark neurodevelopmental processes to examine if pharmaceuticals affect the immature brain.
Master i farmasi Lars Peter Engeset Austdal ved Farmas?ytisk institutt avholder pr?veforelesning over oppgitt emne: Pax6 in development and evolution.
Dr. Rebecca Broomly from University of Manchester will give a lecture on neurodevelopment of children born to mothers with epilepsy.
Master i farmasi Anthony Prandina ved Farmas?ytisk institutt vil forsvare sin avhandling for graden ph.d: Synthesis, Formulation and Biological Evaluations of Chemotherapeutics Targeting Antimicrobial Resistance.
Master i farmasi Anthony Prandina ved Farmas?ytisk institutt avholder pr?veforelesning over oppgitt emne: Bacterial versus human cell metal acquisition strategies.
Biomedical seminar with Professor Wolfgang Maret, Kings College London, UK.
Master i molekyl?rbiologi Julia Isabel Tandberg ved Farmas?ytisk institutt vil forsvare sin avhandling for graden ph.d: Characterization of Piscirickettsia salmonis membrane vesicles and their use as a vaccine for aquaculture.
Master i molekyl?rbiologi Julia Isabel Tandberg ved Farmas?ytisk institutt avholder pr?veforelesning over oppgitt emne: Fish vaccination in Norway, licensed vaccines and future perspectives.
Master i kjemi Cecilia Rossetti ved Farmas?ytisk institutt vil forsvare sin avhandling for graden ph.d: Molecularly Imprinted Polymers as new tool in proteomics:. the case study of SCLC diagnosis.
Master i kjemi Cecilia Rossetti ved Farmas?ytisk institutt avholder pr?veforelesning over oppgitt emne: Interferences and limitations of modern clinical immunoassay.
Master i farmasi Cecilie Rosting ved Farmas?ytisk institutt vil forsvare sin avhandling for graden ph.d: Dried Blood Spots in Liquid Chromatography Mass Spectrometry-based Protein Analysis.
Master i farmasi Cecilie Rosting ved Farmas?ytisk institutt avholder pr?veforelesning over oppgitt emne: Recent developments in protein based drugs and their analyses.
Cand.Pharm. Ragnhild Birkeland Waade ved Farmas?ytisk institutt vil forsvare sin avhandling for graden ph.d: Pharmacological aspects related to the use of antidepressants in elderly patiens.
Cand.Pharm. Ragnhild Birkeland Waade ved Farmas?ytisk institutt avholder pr?veforelesning over oppgitt emne: Therapeutic drug monitoring of psychiatric drugs as a tool for rational use of medicines - pros and cons.
Guest lecture by Professor Dr. Christian Zidorn, Department of Pharmaceutical Biology, Christian-Albrechts-Universit?t (CAU) Kiel, Germany.
Guest lecture by Professor Dr. Birgit Classen, Department of Pharmaceutical Biology, Christian-Albrechts-Universit?t (CAU) Kiel, Germany.